| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis and Metabolism Branch (MD-68), Health Effects Research Laboratory, U. S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711 [J. A. R., J. R. R., S. N., M. J. M]; Integrated Laboratory Systems, Inc., Research Triangle Park, North Carolina, 27709 [G. B. N.]; Environmental Health, Research, and Testing, Inc., Research Triangle Park, North Carolina 27709 [K. H. W.]; Department of Pathology, Medical College of Ohio, Toledo, Ohio 43699 [A. G.]; and Department of Preventive Medicine, Arthur James Cancer Hospital, Ohio State University, Columbus, Ohio 43210 [G. D. S.]
The induction of DNA adducts and adenomas in the lungs of strain A/J mice has been investigated following the single i.p. administration of each of the following polycyclic aromatic hydrocarbons (PAH): pyrene, dibenz[a,h]anthracene, benzo[a]pyrene, benzo[b]fluoranthene, 5-methyl-chrysene, and cyclopenta[c,d]pyrene. DNA adducts were measured by 32P-postlabeling at times between 1 and 21 days following injection, while adenomas were counted at 240 days after treatment. Pyrene did not induce either DNA adducts or lung adenomas at any of the doses examined. Each of the remaining PAH induced both adenomas and DNA adducts in a dose-dependnent manner, with dibenz[a,h]anthracene > 5-methylchrysene > cyclopenta[c,d]pyrene > benzo[a]pyrene > benzo[b]fluoranthene. DNA adducts reached maximal levels between 3 and 9 days after injection, followed by a gradual decrease. The time-integrated DNA adduct level (TIDAL) was calculated by numerically integrating the areas under the adduct persistence curves extrapolated to 240 days for each PAH at each dose level. This value represents the effective total molecular dose of PAH that was delivered to the lung DNA over the entire course of tumorigenesis. A strong correlation of lung adenoma induction with the TIDAL values was observed for each PAH. The slopes of the tumors versus TIDAL value relationships were essentially identical for 5-methyl-chrysene, cyclopenta[cd]pyrene, benzo[a]pyrene, and benzo[b]fluoranthene. The slope of this relationship for dibenz[a,h]anthracene was markedly greater. The essentially identical induction of adenomas as a function of TIDAL values for these PAH suggests that the formation and persistence of DNA adducts determines their carcinogenic potency.
1 Portions of this research were funded by United States Environmental Protection Agency Cooperative Agreement CR-816069 (to G. D. S.). The research described in this article has been reviewed by the Health Effects Research Laboratory, United States Environmental Protection Agency, and approved for publication. Approval does not signify that the contents necessarily reflect the views of the Agency, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.
2 To whom requests for reprints should be addressed.
3 Present address: Duke University, Department of Anesthesiology, Durham, NC 27705.
Received 6/15/94. Accepted 12/30/94.
This article has been cited by other articles:
![]() |
S. A. Leavitt, M. H. George, T. Moore, and J. A. Ross Mutations induced by benzo[a]pyrene and dibenzo[a,l]pyrene in lacI transgenic B6C3F1 mouse lung result from stable DNA adducts Mutagenesis, June 23, 2008; (2008) gen033v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Malmlof, G. Paajarvi, J. Hogberg, and U. Stenius Mdm2 as a Sensitive and Mechanistically Informative Marker for Genotoxicity Induced by Benzo[a]pyrene and Dibenzo[a,l]pyrene Toxicol. Sci., April 1, 2008; 102(2): 232 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C.M. Staal, D. G.A.J. Hebels, M. H.M. van Herwijnen, R. W.H. Gottschalk, F. J. van Schooten, and J. H.M. van Delft Binary PAH mixtures cause additive or antagonistic effects on gene expression but synergistic effects on DNA adduct formation Carcinogenesis, December 1, 2007; 28(12): 2632 - 2640. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gaskell, B. Kaur, P. B. Farmer, and R. Singh Detection of phosphodiester adducts formed by the reaction of benzo[a]pyrene diol epoxide with 2'-deoxynucleotides using collision-induced dissociation electrospray ionization tandem mass spectrometry Nucleic Acids Res., August 1, 2007; 35(15): 5014 - 5027. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bieler, M. G. Cornelius, M. Stiborova, V. M. Arlt, M. Wiessler, D. H. Phillips, and H. H. Schmeiser Formation and persistence of DNA adducts formed by the carcinogenic air pollutant 3-nitrobenzanthrone in target and non-target organs after intratracheal instillation in rats Carcinogenesis, May 1, 2007; 28(5): 1117 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C.M. Staal, M. H.M. van Herwijnen, D. S. Pushparajah, M. Umachandran, C. Ioannides, F. J. van Schooten, and J. H.M. van Delft Modulation of gene expression and DNA-adduct formation in precision-cut liver slices exposed to polycyclic aromatic hydrocarbons of different carcinogenic potency Mutagenesis, January 1, 2007; 22(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C.M. Staal, M. H.M. van Herwijnen, F. J. van Schooten, and J. H.M. van Delft Modulation of gene expression and DNA adduct formation in HepG2 cells by polycyclic aromatic hydrocarbons with different carcinogenic potencies Carcinogenesis, March 1, 2006; 27(3): 646 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jyonouchi, S. Sun, V. A. Porter, and D. N. Cornfield Polycyclic Aromatic Hydrocarbon Diol Epoxides Increase Cytosolic Ca2+ of Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 78 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nesnow, C. Davis, W. T. Padgett, L. Adams, M. Yacopucci, and L. C. King 8,9-Dihydroxy-8,9-dihydrodibenzo[a,l]pyrene is a potent morphological cell-transforming agent in C3H10T1/2Cl8 mouse embryo fibroblasts in the absence of detectable stable covalent DNA adducts Carcinogenesis, June 1, 2000; 21(6): 1253 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Gram Chemically Reactive Intermediates and Pulmonary Xenobiotic Toxicity Pharmacol. Rev., December 1, 1997; 49(4): 297 - 342. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |